Survival outcomes for right- versus left-sided colon cancer and rectal cancer in patients receiving regorafenib and/or trifluridine/tipiracil for refractory metastatic colorectal cancer: Findings from the multicenter retrospective ReTrITa study.

被引：0

作者：

Signorelli, Carlo

Calegari, Maria Alessandra

Passardi, Alessandro

Lucchetti, Jessica

Zurlo, Ina Valeria

Morelli, Cristina

Dell'Aquila, Emanuela

Gemma, Donatello

Emiliani, Alessandra

Arrivi, Giulia

Zoratto, Federica

Chilelli, Mario Giovanni

Morandi, Maria Grazia

Santamaria, Fiorenza

Dettori, Manuela

Cosimati, Antonella

Saltarelli, Rosa

Minelli, Alessandro

Lucci-Cordisco, Emanuela

Basso, Michele

机构：

[1] ASL Viterbo, Belcolle Hosp, Med Oncol Unit, Viterbo, Italy

[2] Fdn Policlin Univ Agostino Gemelli, Comprehens Canc Ctr, Oncol Med, IRCCS, Rome, Italy

[3] IRCCS, Ist Romagnolo Studio Tumori IRST Dino Amadori, Dept Med Oncol, Meldola, Italy

[4] Policlin Univ, Div Med Oncol, Campus Biomed, Rome, Italy

[5] Vito Fazzi Hosp, Med Oncol, Lecce, Italy

[6] Tor Vergata Univ Hosp, Dept Syst Med, Med Oncol Unit, Rome, Italy

[7] IRCCS Regina Elena Natl Canc Inst, Rome, Italy

[8] ASL Frosinone, Med Oncol Unit, Sora, Italy

[9] Isola Tiberina Hosp, Med Oncol, Gemelli Isola, Rome, Italy

[10] Sapienza Univ Rome, St Andrea Univ Hosp, Dept Clin & Mol Med, Oncol Unit, Rome, Italy

[11] ASL Latina, Osped St Maria Goretti, UOC Oncol, Latina, Italy

[12] ASL Rieti, San Camillo Lellis Hosp, Med Oncol Unit, Rieti, Italy

[13] Sapienza Univ Rome, Dept Expt Med, UOC Oncol A, Policlin Umberto I Expt Med,Network Oncol & Precis, Rome, Italy

[14] Osped Oncol Armando Businco, Med Oncol Dept, Cagliari, Italy

[15] UO Oncol Universitaria Casa Salute Aprilia, Med Oncol Dept, Aprilia, Italy

[16] San Giovanni Evangelista Hosp, UOC Oncol, ASL RM5, Tivoli, Italy

[17] Osped San Paolo, Med Oncol Dept, UO Oncol, ASL RM4, Civitavecchia, RM, Italy

[18] Fdn Policlin Univ Agostino Gemelli, Dipartimento Sci V & San Pubbl, UOC Genet Med, IRCCS, Rome, Italy

[19] Fdn Policlin Univ Agostino Gemelli, Comprehens Canc Ctr, Med Oncol Dept, IRCCS, Rome, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 4_SUPPL期

关键词：

D O I：

10.1200/JCO.2025.43.4_suppl.67

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：67 / 67

页数：1

共 50 条

[21] Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis
Basso, Michele
Signorelli, Carlo
Calegari, Maria Alessandra
Lucchetti, Jessica
Zurlo, Ina Valeria
Dell'Aquila, Emanuela
Arrivi, Giulia
Zoratto, Federica
Santamaria, Fiorenza
Saltarelli, Rosa
Trovato, Giovanni
Caira, Giulia
Angotti, Lorenzo
Schirripa, Marta
Anghelone, Annunziato
Schietroma, Francesco
Chilelli, Mario Giovanni
Salvatore, Lisa
Pozzo, Carmelo
Tortora, Giampaolo
TARGETED ONCOLOGY, 2024, 19 (03) : 371 - 382
[22] Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)
Chida, Keigo
Kotani, Daisuke
Moriwaki, Toshikazu
Fukuoka, Shota
Masuishi, Toshiki
Takashima, Atsuo
Kumekawa, Yosuke
Kajiwara, Takeshi
Yamazaki, Kentaro
Komoda, Masato
Makiyama, Akitaka
Denda, Tadamichi
Hatachi, Yukimasa
Suto, Takeshi
Sugimoto, Naotoshi
Enomoto, Masanobu
Ishikawa, Toshiaki
Kashiwada, Tomomi
Ando, Koji
Yuki, Satoshi
Okita, Yoshihiro
Kusaba, Hitoshi
Sakai, Daisuke
Okamoto, Koichi
Tamura, Takao
Yamashita, Kimihiro
Gosho, Masahiko
Shimada, Yasuhiro
FRONTIERS IN ONCOLOGY, 2021, 11
[23] Retrospective study of regorafenib and trifluridine/tipiracil efficacy as a third-line or later chemotherapy regimen for refractory metastatic colorectal cancer
Tanaka, Akira
Sadahiro, Sotaro
Suzuki, Toshiyuki
Okada, Kazutake
Saito, Gota
Miyakita, Hiroshi
ONCOLOGY LETTERS, 2018, 16 (05) : 6589 - 6597
[24] Outcomes of Patients with Metastatic Colorectal Cancer Treated with Trifluridine/Tipiracil beyond the Second Line: A Multicenter Retrospective Study from Saudi Arabia
Alghamdi, Mohammed
Bazarbashi, Shouki
Mahrous, Mervat
Alshaer, Omar
Mostafa Gad, Ahmed
Aseafan, Mohamed
Abdelgelil, Mai
Alshabi, Redhwan Mohammed
Alghanmi, Hosam Ali
Naser, Nasser Ahmed
Al Hariri, Husam
ALHamad, Abdulaziz
Al-Saleh, Khalid
Abdel-Aziz, Nashwa
Elsamany, Sherif
JOURNAL OF ONCOLOGY, 2022, 2022
[25] Regorafenib and trifluridine/tipiracil efficacy and safety in chemorefractory metastatic colorectal cancer patients: A single Bulgarian centre retrospective study
Penkova, M.
Stoyanov, D.
Panayotova, T.
Donev, I.
Petrova, M.
Conev, N.
ANNALS OF ONCOLOGY, 2020, 31 : S100 - S100
[26] HISTOPATHOLOGIC FEATURES AND SURVIVAL OF RIGHT- VERSUS LEFT-SIDED EARLY-ONSET COLORECTAL CANCER.
Good, M. L.
Mankarious, M. M.
Eng, N. L.
Kulaylat, A. S.
Jeganathan, N. A.
Deutsch, M. J.
Koltun, W. A.
Scow, J. S.
DISEASES OF THE COLON & RECTUM, 2022, 65 (05) : 118 - 118
[27] Trifluridine/tipiracil (FTD/TPI) and regorafenib (REG) in patients with metastatic colorectal cancer (mCRC): A single institution retrospective study
Patel, Anuj K.
Ng, Kimmie
Duh, Mei Sheng
Barghout, Victoria E.
Lynn Huynh
Yenikomshian, Mihran Ara
Sharperson, Camara
Brais, Lauren K.
Fuchs, Charles S.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
[28] Comparison of 627 patients with right- and left-sided colon cancer in China: Differences in clinicopathology, recurrence, and survival
Qin Qiong
Yang Lin
Sun Yong-Kun
Ying Jian-Ming
Song Yan
Zhang Wen
Wang Jin-Wan
Zhou Ai-Ping
慢性疾病与转化医学（英文）, 2017, 3 (01) : 51 - 59
[29] Real-world experience of trifluridine/tipiracil in patients with metastatic colorectal cancer: A multicenter United Kingdom study.
Stavraka, Chara
Pouptsis, Athanasios
Kabuubi, Paul
Angelis, Vasileios
Synowiec, Alicja
Baxter, Mark
Barrie, Ainsley
Costa, Amparo Andres
Nizam, Alia
De Naurois, Julien
Mikropoulos, Christos
Hill, Mark
Graham, Janet Shirley
Harris, Victoria
Bridgewater, John A.
Ross, Paul J.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
[30] Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective "Real-World Study"
Coutzac, Clelia
Trouilloud, Isabelle
Pascal, Artru
Henriques, Julie
Masson, Therese
Doat, Solene
Bouche, Olivier
Coriat, Romain
Saint, Angelique
Moulin, Valerie
Vernerey, Dewi
Gallois, Claire
De La Fouchardiere, Christelle
Tougeron, David
Taieb, Julien
CLINICAL COLORECTAL CANCER, 2022, 21 (02) : 132 - 140

← 1 2 3 4 5 →